Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: RAD001 (Everolimus) in combination with carboplatin|DRUG: RAD001 (Everolimus) in combination with carboplatin
Sponsor: Charite University, Berlin, Germany
Collaborators: KKS Netzwerk|Novartis Pharmaceuticals